Ultimele actualizari :
19/11/2024
Citostatic   Pertuzumab  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Perjeta Argentina, Australia, Belgia, Brazilia, Canada, Chilli, Ecuador, Elvetia, Finlanda, Franta, Germania, Irlanda, Islanda, Italia, Japonia, Luxemburg, Marea Britanie, Mexic, Norvegia, Peru, Romania, Slovenia, Spania, SUA, Suedia, Tunisia, Turcia, Ungaria
Bibliografie   Injectabil   Bibliografie : Pertuzumab  
tip publicare
2296 Laborator Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3366 ziar Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A.
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration.
J Pharm Sci 2012 ; DOI 10.1002 / jps.23403
4686 Laborator Pertuzumab (Perjeta®) - Summary of Product Characteristics.
Roche Products Ltd. 2022

  Mentions Légales